F-Prime Capital
Type
investor
Founded
1969
Funding Rounds
15
Portfolio companies
8
About F-Prime Capital
F-Prime enables companies to turn their boldest ambitions into world-changing breakthroughs in life sciences, technology, healthtech + services, and crypto. F-Prime emerged from the same entrepreneurial spirit that transformed Fidelity Investments from a single mutual fund into a global financial institution and are proud to be part of a 50-year legacy of partnering with visionaries.
F-Prime Capital investments captured (15)
| Company Name | Stage | Total Deal Amount | Date |
|---|---|---|---|
 Immuneel Therapeutics | Series B | $10.5m | Jun 8, 2026 |
| ******** | $20.0m | Oct 10, 2025 | |
| ******** | $30.0m | Oct 1, 2025 | |
| ******** | ****** | Apr 17, 2025 | |
| ************ | ***** | Apr 16, 2024 |